First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
Morgan, Gareth J, Dr, Prof, Davies, Faith E, MD, Gregory, Walter M, Prof, Cocks, Kim, MSc, Bell, Sue E, DPhil, Szubert, Alex J, MSc, Navarro-Coy, Nuria, MPhil, Drayson, Mark T, MD, Owen, Roger G, MD, Feyler, Sylvia, MD, Ashcroft, A John, MD, Ross, Fiona, DPhil, Byrne, Jennifer, MD, Roddie, Huw, MD, Rudin, Claudius, MD, Cook, Gordon, MD, Jackson, Graham H, Prof, Child, J Anthony, Prof
Published in The Lancet (British edition) (11.12.2010)
Published in The Lancet (British edition) (11.12.2010)
Get full text
Journal Article
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial
Morgan, Gareth J, Prof, Child, J Anthony, Prof, Gregory, Walter M, Prof, Szubert, Alex J, MSc, Cocks, Kim, MSc, Bell, Sue E, DPhil, Navarro-Coy, Nuria, MPhil, Drayson, Mark T, MD, Owen, Roger G, MD, Feyler, Sylvia, MD, Ashcroft, A John, MD, Ross, Fiona M, DPhil, Byrne, Jennifer, MD, Roddie, Huw, MD, Rudin, Claudius, MD, Cook, Gordon, MD, Jackson, Graham H, Prof, Wu, Ping, MSc, Davies, Faith E, MD
Published in The lancet oncology (01.08.2011)
Published in The lancet oncology (01.08.2011)
Get full text
Journal Article